Merck & Co (MRK)
92.93
+1.48 (1.62%)
NYSE · Last Trade: Nov 13th, 11:13 PM EST
Cidara Therapeutics Stock Soars 42% After-Hours On Merck Buyout Buzz — Retail Traders Eye A Potential Blowout Premiumstocktwits.com
Via Stocktwits · November 13, 2025
As of mid-November 2025, a palpable unease has settled over the technology sector, long the darling of investors and the primary engine of market growth. After a period of unprecedented outperformance, particularly by companies at the forefront of artificial intelligence (AI), tech stocks are now experiencing a noticeable downturn. This
Via MarketMinute · November 13, 2025
Pfizer has a huge dividend yield and a high payout ratio compared to Merck, which could make Merck the more attractive dividend stock.
Via The Motley Fool · November 13, 2025
A $10,000 investment in this diversified fund at its 2011 inception would be worth $51,000 today.
Via The Motley Fool · November 13, 2025
Washington D.C. – November 12, 2025 – Looking back from today, the critical period following a hypothetical, yet highly plausible, U.S. government shutdown in late 2024 served as a stark reminder of the indispensable role of timely economic data. As federal agencies grappled with reopening, the U.S. Labor Department
Via MarketMinute · November 12, 2025
The Nasdaq Composite (NASDAQ: IXIC) experienced back-to-back losses on November 11 and 12, 2025, signaling a significant recalibration in the financial markets. This downturn, primarily driven by growing concerns over stretched valuations in the artificial intelligence (AI) sector and a pronounced rotation of capital into more traditional industries, marks a
Via MarketMinute · November 12, 2025
New York, NY – November 12, 2025 – The Dow Jones Industrial Average (DJIA) has shattered previous records, closing at an all-time high of 48,254.82 today, marking a significant milestone for the venerable index. This historic surge, following another record close yesterday, injects a palpable sense of optimism into the
Via MarketMinute · November 12, 2025
New York, NY – November 12, 2025 – In a remarkable display of market resilience and underlying tension, the Dow Jones Industrial Average (DJIA) has surged past the 48,000-point threshold, closing at an unprecedented 48,015.79. This historic equity rally is unfolding concurrently with a robust ascent in precious metals,
Via MarketMinute · November 12, 2025
The financial markets are currently exhibiting an extraordinary and complex phenomenon: both traditional safe-haven assets, gold and silver, are experiencing robust rallies, while the Dow Jones Industrial Average (DJIA) has simultaneously surged past the 48,000-point mark. As of November 12, 2025, gold prices are trading around $4,105-$4,
Via MarketMinute · November 12, 2025
Value-driven plays abound in the top healthcare stocks.
Via The Motley Fool · November 12, 2025
It's been a year to forget for these two companies, but brighter days are ahead.
Via The Motley Fool · November 12, 2025
The Dow Jones Industrial Average (DJIA) made history on Wednesday, November 12, 2025, surging past the 48,000-point mark for the first time ever, gaining nearly 380 points. This significant rally was fueled by a wave of optimism surrounding the imminent resolution of a protracted U.S. government shutdown, which
Via MarketMinute · November 12, 2025
TotalEnergies and Google have signed a 15-year PPA for renewable electricity. The deal aligns with both companies' goals.
Via Benzinga · November 12, 2025
NEW YORK, NY – November 11, 2025 – The Dow Jones Industrial Average (DJIA) has reached an unprecedented milestone today, soaring to a new all-time high of 47,927.96, a robust gain of 559.33 points (1.2%). This marks the 16th record close for the index this year, sending a
Via MarketMinute · November 11, 2025
New York, NY – November 11, 2025 – The Dow Jones Industrial Average (DJIA) has today surged to an unprecedented all-time high, pushing past significant milestones and reinforcing a complex, yet largely optimistic, sentiment across the financial markets. This monumental achievement signals a robust, albeit cautious, wave of investor confidence, underpinned by
Via MarketMinute · November 11, 2025
A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid growing valuation concerns. This divergence was stark: the tech-heavy Nasdaq struggled, losing 0.2%, while the Dow rallied.
This shift away from tech was triggered by a series of negative catalysts in the AI sector. AI cloud provider CoreWeave slid on disappointing guidance, while chip darling Nvidia pulled back after SoftBank sold its stake. This "hurt the AI trade," dragging down related names like Micron and Oracle.
As capital left tech, it sought safety in "higher quality" defensive names. Health care giants like Merck, Amgen, and Johnson & Johnson saw significant buying, boosting the Dow.
Via StockStory · November 11, 2025
Get insights into the S&P500 index performance on Tuesday. Explore the top gainers and losers within the S&P500 index in today's session.
Via Chartmill · November 11, 2025
Let's have a look at what is happening on the US markets in the middle of the day on Tuesday. Below you can find the top S&P500 gainers and losers in today's session.
Via Chartmill · November 11, 2025
Three large pharmaceutical makers are jockeying for position in the rapidly expanding market for GLP-1 drugs.
Via The Motley Fool · November 11, 2025
New York, NY – November 10, 2025 – The S&P 500 Healthcare sector presented a mixed picture today, with the broader index showing a modest uptick while significant segments, particularly health insurers and some providers, faced considerable downward pressure. This divergence highlights a sector grappling with a flurry of groundbreaking drug
Via MarketMinute · November 10, 2025
New York, NY – November 10, 2025 – In a financial landscape often characterized by extremes, Cliff Asness, the influential co-founder of AQR Capital Management, offers a nuanced yet stark assessment of the current stock market: it is undeniably expensive, but crucially, it does not fit his stringent definition of a bubble.
Via MarketMinute · November 10, 2025
Merck said Saturday its new pill — a possible rival to Regeneron and Amgen — lowered high cholesterol by almost 60%.
Via Investor's Business Daily · November 8, 2025
The biotech sector is currently experiencing a robust rally, a significant turnaround from a period of subdued performance. This resurgence is primarily fueled by a wave of promising drug trial results that are validating extensive research and development efforts across the industry. Investors are demonstrating a renewed appetite for risk,
Via MarketMinute · November 7, 2025
Herkimer, NY – November 7, 2025 – In a significant move signaling a proactive response to the escalating demand for artificial intelligence (AI) expertise in the business world, Herkimer County Community College (Herkimer College) is set to launch a groundbreaking Artificial Intelligence – Business Associate in Applied Science (A.A.S.) Degree Program. This new offering, reported [...]
Via TokenRing AI · November 7, 2025
The overall market may be priced very richly here, but a handful of names haven't been swept up in artificial intelligence (AI)-driven mania.
Via The Motley Fool · November 7, 2025